What is YCBD's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for YCBD?

P/E (TTM) is n/a and 52-week range is $0.33 to $2.56 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s YCBD figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for YCBD?

The company profile lists revenue (TTM) near $22M, net income (TTM) near -$305M, EPS (TTM) near -$0.29 when available from the market-data feed. Figures are informational and may lag live markets.

Where is cbdMD Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Charlotte, North Carolina, US, 11.2M shares outstanding, ISIN US12482W4087 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

cbdMD Inc

$YCBD

Health Care · Pharmaceuticals

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina. The company went IPO on 2017-11-17. Its hemp-derived cannabinoids, include full-spectrum cannabidiol (CBD) formulations, hemp-derived Delta-9 THC products and a range of functional products designed to address key wellness needs, such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. The company operates a multi-brand portfolio anchored by its flagship cbdMD line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Its Paw CBD pet-wellness brand provides tinctures, chews, and topicals for dogs and cats. Its ATRX platform offers non-cannabinoid functional ingredients such as functional mushrooms. Its Herbal Oasis (Oasis) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms.

Employees

Website

www.cbdmd.com/

IPO

2017-11-17

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NYSE MKT LLC

ISIN

US12482W4087

Headquarters

Charlotte, North Carolina, US

Shares outstanding

11.2M

NAICS sector

Manufacturing

Institutional ownership

8.20%

Browse other companiesFree AI scores and summaries for more stocks